Pyramid Biosciences
Needham
About Pyramid Biosciences
Pyramid Biosciences is dedicated to discovering and developing targeted therapeutics for a wide range of disorders that are regulated by the tropomyosin receptor kinase (TRK) family. By precisely and selectively modulating the actions of these fundamental cell surface receptors, we can control the key signaling pathways responsible for a patient’s disease, condition, or symptoms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $61.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2021)
- Website: pyramidbio.com
- Phone: (502) 589-5400
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/pyramid-biosciences-71440 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.